Biosyngen Announces FDA Fast Track Designation For BST02 In Treatment Of Liver Cancer
SINGAPORE, Feb. 1, 2024 /PRNewswire/ -- Biosyngen is proud to announce that its latest groundbreaking product, BST02, has been granted Fast Track Designation (FTD) by the U.S. Food and Drug Administration (FDA) for the treatment of all types of... (Source: Drugs.com - Clinical Trials)
Source: Drugs.com - Clinical Trials - February 1, 2024 Category: Pharmaceuticals Source Type: clinical trials
Impact of Graft Reconditioning With Hypothermic Machine Perfusion on HCC Recurrence After Liver Transplantation
Conditions: Hepatocellular Carcinoma; Liver Transplant; Complications Interventions: Device: D-HOPE machine perfusion; Procedure: Liver transplantation Sponsors: Azienda Ospedaliero-Universitaria di Modena Recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - February 1, 2024 Category: Research Source Type: clinical trials
Association Between Pre-op Non-Selective Beta-Blockers and Hepatocellular Carcinoma Recurrence Post-Liver Transplant
Conditions: Hepatocellular Carcinoma Recurrent; Hepatocellular Carcinoma Interventions: Drug: Non-Selective Beta-Adrenoreceptor Agonists for Systemic Use Sponsors: Asan Medical Center; Korea Health Industry Development Institute Completed (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - January 31, 2024 Category: Research Source Type: clinical trials
Adebrelimab Plus Cetuximab and Chemotherapy for Patients With RAS/BRAF Wild-Type Unresectable Liver Metastases Colorectal Cancer
Conditions: Metastatic Colorectal Cancer Interventions: Drug: Adebrelimab + Cetuximab+ Chemotherapy Sponsors: The First Affiliated Hospital of Zhengzhou University Recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - January 30, 2024 Category: Research Source Type: clinical trials
Daily Step Count Using Pedometer for Sarcopenic Management in Patient With Cirrhosis: Randomized Controlled Trial
Conditions: Sarcopenia; Cirrhosis, Liver; Daily Step Count Interventions: Other: Encourage using pedometer; Device: pedometer Sponsors: Mahidol University Enrolling by invitation (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - January 30, 2024 Category: Research Source Type: clinical trials
Bloody or Well Done. How Would You Like Your Liver Biopsy, Sir?
Conditions: Liver Disease Parenchymal Interventions: Procedure: Group one - percutaneous (P); Procedure: Group two - EUS FNB (E) Sponsors: Carol Davila University of Medicine and Pharmacy Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - January 30, 2024 Category: Research Source Type: clinical trials
Assessment of surgical risk in patients with chronic liver disease using vocal penn score
Conditions: CHRONIC LIVER DISEASE Interventions: Procedure: patients with liver disease who undergoing surgery; Procedure: patients with liver disease who do not undergoing surgery Sponsors: Asian Institute of Gastroenterology, India Recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - January 29, 2024 Category: Research Source Type: clinical trials
Role of Oral Zinc in Reducing Neonatal Indirect Hyperbilirubinemia
Conditions: Neonatal Jaundice Interventions: Drug: Oral zinc sulfate and standard phototherapy Sponsors: National Liver Institute, Egypt Completed (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - January 29, 2024 Category: Research Source Type: clinical trials
Analysis of PD-L1, TMB, MSI and ctDNA Dynamics to Predict and Monitor Response to Immunotherapy in Metastatic Cancer.
Conditions: Non Small Cell Lung Cancer; Breast Cancer; Colorectal Cancer; Gastric Cancer; Liver Cancer; Advanced Cancer; Immune Checkpoint Inhibitor Sponsors: Gene Solutions Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - January 29, 2024 Category: Research Source Type: clinical trials
Sotevtamab (AB-16B5) Combined With FOLFOX as Neoadjuvant Treatment Prior to Resection of Colorectal Cancer Liver Metastasis
Conditions: Metastatic Colorectal Cancer Interventions: Biological: Sotevtamab; Combination Product: FOLFOX Sponsors: Alethia Biotherapeutics Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - January 26, 2024 Category: Research Source Type: clinical trials
Focused Power Ultrasound Mediated Inferior Perirenal Adipose Tissue Modification Therapy for Non-Alcoholic Fatty Liver Disease (PARADISE-NAFLD)
Conditions: Non-alcoholic Fatty Liver Disease Interventions: Device: focused power ultrasound mediated inferior perirenal adipose tissue modification; Device: sham-control group Sponsors: The First Affiliated Hospital with Nanjing Medical University; The Affiliated Jiangning Hospital of Nanjing Medical University; Suzhou Municipal Hospital Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - January 26, 2024 Category: Research Source Type: clinical trials
Predictive Values of Presepsin Levels in ASciteS in Patients With Chronic Liver Failure
Conditions: Ascites Hepatic; Liver Failure; Cirrhosis, Liver Interventions: Diagnostic Test: Determination of presepsin levels in ascites Sponsors: Carol Davila University of Medicine and Pharmacy Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - January 25, 2024 Category: Research Source Type: clinical trials
Retrospective Exploratory Analysis of Donor-derived Cell Free DNA in Liver Transplant Patients
Conditions: Liver Transplant Failure Interventions: Behavioral: donor-derived cell free DNA in liver Sponsors: Methodist Health System Recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - January 25, 2024 Category: Research Source Type: clinical trials
Exploratory Analysis of Enhanced Liver Function (ELF) Test to Detect Early Fatty Liver in High Risk Population
Conditions: Fatty Liver Sponsors: Methodist Health System Recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - January 25, 2024 Category: Research Source Type: clinical trials
Examining the Use of a Novel Immersive Motion Tracking Upper Extremity Exercise Program for Acute Hospitalized Patients
Conditions: Kidney Transplant; Liver Transplant Interventions: Device: MoveMend Health Sponsors: NYU Langone Health Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - January 24, 2024 Category: Research Source Type: clinical trials
